Alexandra B. Maulden

Associate

Overview

Alexandra (Alex) Maulden is an associate with Foley & Lardner LLP and a member of the firm’s Health Care Practice Group in the Boston office.

During law school, Alex was selected for the Mayo-Foley Health Law Fellowship, consisting of summer internships with the Mayo Clinic Legal Department in Rochester, Minnesota and Foley’s Boston office. During this time, she assisted attorneys at both the Mayo Clinic and Foley with a broad range of regulatory compliance and transactional matters. While in law school, she also interned with the Whistleblower Law Collaborative where she researched a variety of issues relating to health care fraud and abuse, with a specific focus on the Coronavirus Relief Fund.

Before law school, Alex was a clinical research assistant in the Emergency Department at Boston Children’s Hospital, where she coordinated with medical staff to identify eligible research study patients and discussed study procedures with patients.

Education

  • Boston University School of Law (J.D., cum laude, 2022)
    • Concentration in Health Law with Honors
    • Senior Articles Editor, American Journal of Law and Medicine
    • Vice President, Health Law Association
  • Colgate University (B.A., 2016)
    • Beta Beta Beta National Biological Honor Society

Publications

  • Author, “Ignoring the Experts: Implications of the FDA’s Aduhelm Approval” 48 American Journal of Law and Medicine 108-133 (July 11, 2022)
  • Co-author, “United States,” The Healthcare Law Review (July 30, 2021)
  • Author, “Wearables and the FDA: Lessons from the COVID-19 Pandemic,” DOME BLOG (June 28, 2021)
  • Co-Author, “11th Circuit FCA Ruling Takes Practical Approach to Materiality,” Law360 (July 8, 2020)
  • Co-Author, “Diagnostic Performance of C6 Enzyme Immunoassay for Lyme Arthritis,” Pediatrics (January 1, 2020)
  • Co-Author, “Positive 2-Tiered Lyme Disease Serology is Uncommon in Asymptomatic Children Living in Endemic Areas of the United States,” Pediatric Infectious Disease Journal (May 2019)
  • Author, “Two-tier Lyme Disease Serology Test Results Vary By First-tier Test,” Pediatric Journal of Infectious Disease Society (February 22, 2019)
  • Co-Author, “C-Reactive Protein or Erythrocyte Sedimentation Rate Results Reliably Exclude Invasive Bacterial Infections,” The American Journal of Emergency Medicine (November 8, 2018)
  • Co-Author, “Accuracy of Clinician Suspicion of Lyme Disease in the Emergency Department,” Pediatrics (September 21, 2017)

Admissions

  • Massachusetts

Capabilities